The vector of anti-mesothelin chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human mesothelin. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-mesothelin antibody linked to CD3ζ and 4-1BB (CD137) signaling domains. And the vector product was designed for the treatment of pancreatic cancer, ovarian cancer, lung cancer, malignant pleural mesothelioma tumors (MPM tumors).
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|OAdCmodV-YX1711||Oncolytic Adenovirus (Capsid modified Ad5, pCMV-Δ24/55k, Anti-MSLN), Viral particle|
|CAR-LC083||Anti-Mesothelin (M18) h(41BB-CD3ζ) CAR, pCDCAR1|
|OAdCmodV-YX1715||Oncolytic Adenovirus (Capsid modified Ad5, pCMV-Δ19k, Anti-MSLN-1), Viral particle|
|CAR-LC370||Anti-MSLN (SS1) h(KIR2DS2, DAP12) Armoured CAR, pCDCAR1|
|VP-CAR-LC572||Lenti-Mesothelin CAR (scFv-41BB-CD3ζ, M18) Viral Particle|
|VP-CAR-LC525||Lenti-Mesothelin CAR (scFv-CD3ζ, m912) Viral Particle|
|CAR-LC081||Anti-Mesothelin (M16) h(41BB-CD3ζ) CAR, pCDCAR1|
|VP-CAR-LC353||Lenti-Mesothelin CAR (scFv-CD28, SS1) Viral Particle|
|VP-CAR-LC560||Lenti-Mesothelin CAR (scFv-41BB-CD3ζ, M6) Viral Particle|
|OAdCmodV-YX1716||Oncolytic Adenovirus (Capsid modified Ad5, pCMV-Δ19k, Anti-MSLN-2), Viral particle|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved